NOGRADERM

Serial Number 79300000
Registration 6617202
700

Registration Progress

Application Filed
Sep 28, 2020
Under Examination
Approved for Publication
Nov 2, 2021
Published for Opposition
Nov 2, 2021
Registered
Jan 18, 2022

Trademark Image

NOGRADERM

Basic Information

Serial Number
79300000
Registration Number
6617202
Filing Date
September 28, 2020
Registration Date
January 18, 2022
Published for Opposition
November 2, 2021
Drawing Code
3000

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 18, 2022
Registration
Registered
Classes
005

Rights Holder

Nogra Pharma Limited

99
Address
33 Sir John Rogerson's Quay
Dublin2
IE

Ownership History

Nogra Pharma Limited

Original Applicant
99
IE

Nogra Pharma Limited

Owner at Publication
99
IE

Nogra Pharma Limited

Original Registrant
99
IE

Legal Representation

Attorney
Michael A. Marrero

USPTO Deadlines

Next Deadline
895 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-01-18)
Due Date
January 18, 2028
Grace Period Ends
July 18, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

36 events
Date Code Type Description Documents
Jul 18, 2022 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Jun 28, 2022 FIMP P FINAL DISPOSITION PROCESSED Loading...
Jun 28, 2022 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Apr 18, 2022 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jan 19, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 19, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 19, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 18, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 2, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 2, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 13, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 26, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Sep 26, 2021 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Sep 26, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Sep 26, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Sep 26, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 23, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 22, 2021 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Sep 22, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 24, 2021 CNFR R FINAL REFUSAL WRITTEN Loading...
Aug 24, 2021 GNFR O FINAL REFUSAL E-MAILED Loading...
Aug 24, 2021 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Jul 27, 2021 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Jul 27, 2021 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Loading...
Jul 23, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 22, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 22, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 22, 2021 RFNT P REFUSAL PROCESSED BY IB Loading...
Mar 4, 2021 RFRR P REFUSAL PROCESSED BY MPU Loading...
Mar 4, 2021 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Feb 28, 2021 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Feb 27, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 20, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 22, 2020 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Dec 18, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 17, 2020 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of immune-inflammatory mediated dermatological diseases and conditions, such as acne and psoriasis, and skin diseases and disorders; medicated dermatological preparations; antibiotic dermatological products; dermatological pharmaceutical substances; dermatological pharmaceutical products; medicated gels for dermatological use; medicated creams for dermatological use
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of two interlocking/intersecting blue ovals to the left of wording "NOGRADERM" with "NOGRA" in blue and "DERM" in black.
Color Claim
The color(s) blue and black is/are claimed as a feature of the mark.

Classification

International Classes
005